Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by material
Polymeric stents
Metallic stents
PART 07: Market segmentation by application
Market overview
PART 08: Market segmentation by end-user
Hospitals
ASCs
PART 09: Geographical segmentation
Bioabsorbable stents market in the Americas
Bioabsorbable stents market in EMEA
Bioabsorbable stents market in APAC
PART 10: Market drivers
Increasing prevalence of CADs
Growing demand for MI procedures
Growing diabetic population
PART 11: Impact of drivers
PART 12: Market challenges
Stringent regulation for approval of devices
Threat of substitute products
Increasing competition among vendors
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advent of metallic stents
Growing popularity of hybrid procedures
Alternative use of vascular stents
PART 15: Vendor landscape
Competitive landscape analysis
PART 16: Key vendor analysis
Boston Scientific
Abbott Laboratories
Elixir Medical
Kyoto Medical Planning
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio



List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global bioabsorbable stents market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global bioabsorbable stents market by material 2016
Exhibit 05: Polymeric stents: Market overview
Exhibit 06: Polymeric stents: Products
Exhibit 07: Metallic stents: Market overview
Exhibit 08: Metallic stents: Products
Exhibit 09: Global bioabsorbable stents market by application 2016
Exhibit 10: Global bioabsorbable stents market by end-users 2016
Exhibit 11: Revascularisation procedures in Americas 2006 and 2013 (per 100,000 population)
Exhibit 12: Revascularisation procedures in EMEA 2006 and 2013 (per 100,000 population)
Exhibit 13: Revascularisation procedures in APAC 2006 and 2013 (per 100,000 population)
Exhibit 14: Bioabsorbable stents market: ASCs in Americas
Exhibit 15: Bioabsorbable stents market: ASCs in EMEA
Exhibit 16: Bioabsorbable stents market: ASCs in APAC
Exhibit 17: Americas: Overview of bioabsorbable stents market
Exhibit 18: Bioabsorbable stents market in Americas 2016-2021 ($ billions)
Exhibit 19: Americas: Market metrics in various countries
Exhibit 20: Key takeaway: Bioabsorbable stents market in the US
Exhibit 21: EMEA: Overview of bioabsorbable stents market
Exhibit 22: Bioabsorbable stents market in EMEA 2016-2021 ($ billions)
Exhibit 23: EMEA: Market metrics in various countries
Exhibit 24: Key takeaway: Bioabsorbable stents market in the UK
Exhibit 25: APAC: Overview of bioabsorbable stents market
Exhibit 26: Bioabsorbable stents market in APAC 2016-2021 ($ billions)
Exhibit 27: APAC: Market metrics in various countries
Exhibit 28: Key takeaway: Bioabsorbable stents market in India
Exhibit 29: CHD prevalence by sex and age in US 2015
Exhibit 30: Global prevalence of diabetes 2015 and 2040 (millions)
Exhibit 31: Impact of drivers
Exhibit 32: Bioabsorbable stents under investigation and trials
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global bioabsorbable stents market 2016
Exhibit 35: Competitive landscape analysis of global bioabsorbable stents market 2016
Exhibit 36: Market penetration of various bioabsorbable stents manufacturers globally 2016
Exhibit 37: Strategic factors determining success for leading companies in global bioabsorbable stents market
Exhibit 38: Boston Scientific: Strength analysis
Exhibit 39: Boston Scientific: Strategy assessment
Exhibit 40: Boston Scientific: Opportunity assessment
Exhibit 41: Abbott Laboratories: Strength assessment
Exhibit 42: Abbott Laboratories: Strategy assessment
Exhibit 43: Abbott Laboratories: Opportunity assessment
Exhibit 44: Elixir Medical: Strength assessment
Exhibit 45: Elixir Medical: Strategy assessment
Exhibit 46: Elixir Medical: Opportunity assessment
Exhibit 47: Kyoto Medical Planning: Strength assessment
Exhibit 48: Kyoto Medical Planning: Strategy assessment
Exhibit 49: Kyoto Medical Planning: Opportunity assessment
Exhibit 50: Other prominent vendors: Bioabsorbable stents market


Companies Mentioned
Boston Scientific, Abbott Laboratories, Elixir Medical, Kyoto Medical Planning, REVA Medical, Arterial Remodeling Technologies, Tepha, Meril Life Sciences, Amaranth Medical, Arterius.